EP1572724A4 - Peptides liant des recepteurs kdr et vegf/kdr et leurs utilisations en diagnostic et therapie - Google Patents
Peptides liant des recepteurs kdr et vegf/kdr et leurs utilisations en diagnostic et therapieInfo
- Publication number
- EP1572724A4 EP1572724A4 EP03711418A EP03711418A EP1572724A4 EP 1572724 A4 EP1572724 A4 EP 1572724A4 EP 03711418 A EP03711418 A EP 03711418A EP 03711418 A EP03711418 A EP 03711418A EP 1572724 A4 EP1572724 A4 EP 1572724A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- kdr
- vegf
- diagnosis
- therapy
- binding peptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 101100372758 Danio rerio vegfaa gene Proteins 0.000 title 1
- 101150030763 Vegfa gene Proteins 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
- A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
- A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08008365A EP2014310B8 (fr) | 2002-03-01 | 2003-03-03 | Peptides de liaison KDR et VEGF/KDR et leur utilisation pour le diagnostic et la thérapie |
EP10185498.2A EP2301587B1 (fr) | 2002-03-01 | 2003-03-03 | Peptides de liaison KDR et VEGF/KDR et leur utilisation pour le diagnostic et la thérapie |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36085102P | 2002-03-01 | 2002-03-01 | |
US360851P | 2002-03-01 | ||
US44041103P | 2003-01-15 | 2003-01-15 | |
US440411P | 2003-01-15 | ||
PCT/US2003/006731 WO2003074005A2 (fr) | 2002-03-01 | 2003-03-03 | Peptides liant des recepteurs kdr et vegf/kdr et leurs utilisations en diagnostic et therapie |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10185498.2A Division EP2301587B1 (fr) | 2002-03-01 | 2003-03-03 | Peptides de liaison KDR et VEGF/KDR et leur utilisation pour le diagnostic et la thérapie |
EP08008365A Division EP2014310B8 (fr) | 2002-03-01 | 2003-03-03 | Peptides de liaison KDR et VEGF/KDR et leur utilisation pour le diagnostic et la thérapie |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1572724A2 EP1572724A2 (fr) | 2005-09-14 |
EP1572724A4 true EP1572724A4 (fr) | 2007-03-14 |
Family
ID=27791656
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10185498.2A Expired - Lifetime EP2301587B1 (fr) | 2002-03-01 | 2003-03-03 | Peptides de liaison KDR et VEGF/KDR et leur utilisation pour le diagnostic et la thérapie |
EP03711418A Withdrawn EP1572724A4 (fr) | 2002-03-01 | 2003-03-03 | Peptides liant des recepteurs kdr et vegf/kdr et leurs utilisations en diagnostic et therapie |
EP08008365A Expired - Lifetime EP2014310B8 (fr) | 2002-03-01 | 2003-03-03 | Peptides de liaison KDR et VEGF/KDR et leur utilisation pour le diagnostic et la thérapie |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10185498.2A Expired - Lifetime EP2301587B1 (fr) | 2002-03-01 | 2003-03-03 | Peptides de liaison KDR et VEGF/KDR et leur utilisation pour le diagnostic et la thérapie |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP08008365A Expired - Lifetime EP2014310B8 (fr) | 2002-03-01 | 2003-03-03 | Peptides de liaison KDR et VEGF/KDR et leur utilisation pour le diagnostic et la thérapie |
Country Status (7)
Country | Link |
---|---|
EP (3) | EP2301587B1 (fr) |
JP (2) | JP2006514915A (fr) |
AU (2) | AU2003213730A1 (fr) |
CA (2) | CA2477836A1 (fr) |
ES (2) | ES2398393T3 (fr) |
SI (1) | SI2301587T1 (fr) |
WO (1) | WO2003074005A2 (fr) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002335930B2 (en) | 2001-03-09 | 2005-07-28 | Morphosys Ag | Serum albumin binding moieties |
US20050250700A1 (en) * | 2002-03-01 | 2005-11-10 | Sato Aaron K | KDR and VEGF/KDR binding peptides |
US8623822B2 (en) | 2002-03-01 | 2014-01-07 | Bracco Suisse Sa | KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy |
AU2003278807A1 (en) | 2002-03-01 | 2004-08-13 | Bracco International B.V. | Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
US7666979B2 (en) * | 2002-03-01 | 2010-02-23 | Bracco International B.V. | Methods for preparing multivalent constructs for therapeutic and diagnostic applications and methods of preparing the same |
US7794693B2 (en) | 2002-03-01 | 2010-09-14 | Bracco International B.V. | Targeting vector-phospholipid conjugates |
US7261876B2 (en) | 2002-03-01 | 2007-08-28 | Bracco International Bv | Multivalent constructs for therapeutic and diagnostic applications |
US7211240B2 (en) | 2002-03-01 | 2007-05-01 | Bracco International B.V. | Multivalent constructs for therapeutic and diagnostic applications |
CA2477935C (fr) * | 2002-03-01 | 2015-01-06 | Bracco International Bv | Produits de synthese multivalents pour applications therapeutiques et diagnostiques |
NO20026286D0 (no) * | 2002-12-30 | 2002-12-30 | Amersham Health As | Nye peptider |
EP1590006B1 (fr) | 2003-02-04 | 2010-09-08 | Bracco Suisse SA | Agents de contraste pour ultrasons et procede pour leur elaboration |
EP2161037A3 (fr) * | 2003-04-22 | 2010-05-26 | Ipsen Pharma | Conjugués de Camptothecin-Somatostatin |
CA2547024C (fr) | 2003-12-22 | 2013-12-17 | Bracco Research Sa | Systeme de microvesicule remplie de gaz pour l'imagerie de contraste |
EP1750671B1 (fr) | 2004-06-03 | 2008-10-15 | Bracco Research S.A. | Assemblage liposomale pour son utilisation therapeutique et/ou diagnostique |
JP4837663B2 (ja) | 2004-08-18 | 2011-12-14 | ブラッコ・シュイス・ソシエテ・アノニム | 造影画像化のためのガス充填微小胞組成物 |
US20060160157A1 (en) * | 2005-01-19 | 2006-07-20 | Zuckerman Mathew M | Method, compositions and classification for tumor diagnostics and treatment |
EP1714642A1 (fr) | 2005-04-18 | 2006-10-25 | Bracco Research S.A. | Formulation pharmaceutique comprenant des microcapsules remplies de gaz pour la délibération échographique |
WO2007067979A2 (fr) * | 2005-12-09 | 2007-06-14 | Bracco International B.V. | Conjugués vecteur de ciblage-phospholipides |
WO2008028917A1 (fr) | 2006-09-05 | 2008-03-13 | Bracco Research Sa | Microvésicules remplies de gaz contenant des lipides modifiés par polymères |
WO2008075192A2 (fr) * | 2006-12-19 | 2008-06-26 | Bracco International Bv | Composés de ciblage et composés thérapeutiques, et microvésicules remplies de gaz comprenant lesdits composés |
WO2010040772A2 (fr) | 2008-10-07 | 2010-04-15 | Bracco Research Sa | Construction de ciblage comprenant un anticorps anti-polymere et des liposomes ou des microvesicules se liant à ceux-ci |
WO2011046991A2 (fr) * | 2009-10-15 | 2011-04-21 | Gilead Connecticut, Inc. | Certaines urées substituées comme modulateurs de l'activité de kinases |
CN105026030B (zh) | 2012-12-21 | 2017-04-12 | 博莱科瑞士股份有限公司 | 充气微泡 |
US11027030B2 (en) | 2014-08-29 | 2021-06-08 | Anmi S.A. | Kit for radiolabelling |
BE1021191B1 (fr) * | 2014-08-29 | 2015-10-27 | Anmi S.A. | Kit pour radiomarquage. |
HUE043680T2 (hu) | 2014-12-18 | 2019-09-30 | Bracco Suisse Sa | Célbajuttató gázzal töltött mikrorészecske készítmény |
US10688199B2 (en) | 2015-06-10 | 2020-06-23 | Teikyo University | Theranostic bubble preparation (TB), and method for using same |
TR201723077A2 (tr) * | 2017-12-29 | 2019-07-22 | Ege Ueniversitesi | Ultrases duyarli manyeti̇k hedefli̇ nano i̇laç taşiyici si̇stem |
US20200360289A1 (en) | 2019-05-15 | 2020-11-19 | Bracco Suisse Sa | Freeze-dried product and gas-filled microvesicles suspension |
US11717570B2 (en) | 2019-05-15 | 2023-08-08 | Bracco Suisse Sa | Gas-filled microvesicles |
EP4178948A2 (fr) | 2020-07-29 | 2023-05-17 | Universidade de Santiago de Compostela | Isonitriles fonctionnalisés et produits associés, leur préparation et leurs utilisations |
CN113740539B (zh) * | 2021-08-11 | 2023-07-25 | 中元汇吉生物技术股份有限公司 | 一种测定特异性生长因子的试剂盒 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000063380A1 (fr) * | 1999-04-16 | 2000-10-26 | Genentech, Inc. | Variants du facteur de croissance endotheliale et utilisations correspondantes |
WO2001052875A1 (fr) * | 2000-01-18 | 2001-07-26 | Ludwig Institute For Cancer Research | Inhibiteur peptidomimetique de vegf-d/vegf-c/vegf |
WO2002016412A2 (fr) * | 2000-08-18 | 2002-02-28 | Dyax Corp. | Polypeptides de liaison pour proteine stimulatrice des lymphocytes b (blys) |
Family Cites Families (91)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4093709A (en) | 1975-01-28 | 1978-06-06 | Alza Corporation | Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates) |
US4131648A (en) | 1975-01-28 | 1978-12-26 | Alza Corporation | Structured orthoester and orthocarbonate drug delivery devices |
US4180646A (en) | 1975-01-28 | 1979-12-25 | Alza Corporation | Novel orthoester polymers and orthocarbonate polymers |
US4391797A (en) | 1977-01-05 | 1983-07-05 | The Children's Hospital Medical Center | Systems for the controlled release of macromolecules |
US4718433A (en) | 1983-01-27 | 1988-01-12 | Feinstein Steven B | Contrast agents for ultrasonic imaging |
DE3313946A1 (de) | 1983-04-15 | 1984-10-18 | Schering AG, 1000 Berlin und 4709 Bergkamen | Mikropartikel und gasblaeschen enthaltende ultraschall-kontrastmittel |
DE3313947A1 (de) | 1983-04-15 | 1984-10-18 | Schering AG, 1000 Berlin und 4709 Bergkamen | Mikropartikel und gasblaeschen enthaltende ultraschall-kontrastmittel |
DE3834705A1 (de) | 1988-10-07 | 1990-04-12 | Schering Ag | Ultraschallkontrastmittel aus gasblaeschen und fettsaeure enthaltenden mikropartikeln |
US4900540A (en) | 1983-06-20 | 1990-02-13 | Trustees Of The University Of Massachusetts | Lipisomes containing gas for ultrasound detection |
US4899755A (en) | 1985-05-08 | 1990-02-13 | The General Hospital Corporation | Hepatobiliary NMR contrast agents |
MX174467B (es) | 1986-01-23 | 1994-05-17 | Squibb & Sons Inc | 1,4,7-triscarboximetil-1,4,7,10-tetraazaciclodo decano substituido en 1 y compuestos analogos |
US5021556A (en) | 1987-07-22 | 1991-06-04 | Neorx Corporation | Method of radiolabeling chelating compounds comprising sulfur atoms with metal radionuclides |
DE3726264A1 (de) | 1987-08-07 | 1989-02-16 | Bayer Ag | Verfahren zur herstellung von feuchtigkeitshaertenden bindemittelkompositionen und ihre verwendung |
US4844882A (en) | 1987-12-29 | 1989-07-04 | Molecular Biosystems, Inc. | Concentrated stabilized microbubble-type ultrasonic imaging agent |
IE61591B1 (en) | 1987-12-29 | 1994-11-16 | Molecular Biosystems Inc | Concentrated stabilized microbubble-type ultrasonic imaging agent and method of production |
US5075099A (en) | 1988-05-31 | 1991-12-24 | Neorx Corporation | Metal radionuclide chelating compounds for improved chelation kinetics |
US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
US5364613A (en) | 1989-04-07 | 1994-11-15 | Sieving Paul F | Polychelants containing macrocyclic chelant moieties |
US5118797A (en) | 1989-08-28 | 1992-06-02 | E. R. Squibb & Sons, Inc. | Rhenium tris dioxime complexes |
EP0489869B1 (fr) | 1989-08-28 | 1998-11-11 | The General Hospital Corporation | Chelates metalliques d'hydroxy-aryle d'imagerie par resonnance magnetique nucleaire de diagnostic |
US5230882A (en) | 1989-12-22 | 1993-07-27 | Unger Evan C | Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same |
US5585112A (en) | 1989-12-22 | 1996-12-17 | Imarx Pharmaceutical Corp. | Method of preparing gas and gaseous precursor-filled microspheres |
US5123414A (en) | 1989-12-22 | 1992-06-23 | Unger Evan C | Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same |
US5469854A (en) | 1989-12-22 | 1995-11-28 | Imarx Pharmaceutical Corp. | Methods of preparing gas-filled liposomes |
CA2034042C (fr) | 1990-01-18 | 1999-08-17 | Adrian D. Nunn | Produits d'addition de l'acide boronique et de complexes rhenium-dioxime et technetium-99m-dioxime, contenant un groupe a activite biochimique |
US5556610A (en) | 1992-01-24 | 1996-09-17 | Bracco Research S.A. | Gas mixtures useful as ultrasound contrast media, contrast agents containing the media and method |
US5445813A (en) | 1992-11-02 | 1995-08-29 | Bracco International B.V. | Stable microbubble suspensions as enhancement agents for ultrasound echography |
US5578292A (en) | 1991-11-20 | 1996-11-26 | Bracco International B.V. | Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof |
IN172208B (fr) | 1990-04-02 | 1993-05-01 | Sint Sa | |
US5183653A (en) | 1990-04-13 | 1993-02-02 | E. R. Squibb & Sons, Inc. | Boronic acid adducts of metal dioxime complexes useful in labelling proteins and other amine-containing compounds |
US5137928A (en) | 1990-04-26 | 1992-08-11 | Hoechst Aktiengesellschaft | Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents |
AU636481B2 (en) | 1990-05-18 | 1993-04-29 | Bracco International B.V. | Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography |
US5367080A (en) | 1990-11-08 | 1994-11-22 | Sterling Winthrop Inc. | Complexing agents and targeting radioactive immunoreagents useful in therapeutic and diagnostic imaging compositions and methods |
US5849261A (en) | 1991-02-08 | 1998-12-15 | Diatide, Inc. | Radiolabeled vasoactive intestinal peptides for diagnosis and therapy |
KR930703024A (ko) | 1991-02-08 | 1993-11-29 | 리챠드 티. 딘 | 영상용 테크네튬-99m표지폴리펩티드 |
US5965107A (en) | 1992-03-13 | 1999-10-12 | Diatide, Inc. | Technetium-99m labeled peptides for imaging |
GB9106673D0 (en) | 1991-03-28 | 1991-05-15 | Hafslund Nycomed As | Improvements in or relating to contrast agents |
GB9106686D0 (en) | 1991-03-28 | 1991-05-15 | Hafslund Nycomed As | Improvements in or relating to contrast agents |
DK0586524T3 (fr) | 1991-06-03 | 1997-05-20 | Nycomed Imaging As | |
CA2112109A1 (fr) | 1991-07-05 | 1993-01-21 | Arne Berg | Produits de contraste ou elements connexes ameliores |
US5808091A (en) | 1991-10-29 | 1998-09-15 | Bracco International B.V. | Rhenium and technetium complexes containing a hypoxia localizing moiety |
GB9200391D0 (en) | 1992-01-09 | 1992-02-26 | Nycomed As | Improvements in or relating to contrast agents |
GB9200387D0 (en) | 1992-01-09 | 1992-02-26 | Nycomed As | Improvements in or relating to contrast agents |
GB9200388D0 (en) | 1992-01-09 | 1992-02-26 | Nycomed As | Improvements in or relating to contrast agents |
IL104084A (en) | 1992-01-24 | 1996-09-12 | Bracco Int Bv | Sustainable aqueous suspensions of pressure-resistant and gas-filled blisters, their preparation, and contrast agents containing them |
US5608110A (en) | 1993-06-15 | 1997-03-04 | Bracco International B.V. | Heteroatom-bearing ligands and metal complexes thereof |
JP2905598B2 (ja) | 1993-07-02 | 1999-06-14 | モレキュラー バイオシステムズ,インコーポレイテッド | 熱変性されたタンパク質からカプセル化されたマイクロスフェアを製造する方法 |
WO1995003280A1 (fr) | 1993-07-19 | 1995-02-02 | Resolution Pharmaceuticals Inc. | Chelateurs de radionucleides de type hydrazino presentant une configuration n3s |
US5798091A (en) | 1993-07-30 | 1998-08-25 | Alliance Pharmaceutical Corp. | Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement |
US5574140A (en) | 1993-09-03 | 1996-11-12 | Resolution Pharmaceutical Inc. | Hydrazino-type N2 S2 chelators |
PT682530E (pt) | 1993-12-15 | 2003-06-30 | Bracco Research Sa | Misturas de gases uteis como meios de contraste para ultrassons |
GB9402867D0 (en) | 1994-02-15 | 1994-04-06 | Nycomed Imaging As | Improvements in or relating to contrast agents |
JP2891647B2 (ja) | 1994-03-11 | 1999-05-17 | 株式会社日本触媒 | 有機スルフィド化合物及びその製造方法 |
US5770565A (en) | 1994-04-13 | 1998-06-23 | La Jolla Cancer Research Center | Peptides for reducing or inhibiting bone resorption |
US5582814A (en) | 1994-04-15 | 1996-12-10 | Metasyn, Inc. | 1-(p-n-butylbenzyl) DTPA for magnetic resonance imaging |
DE69534990T2 (de) | 1994-04-20 | 2006-10-05 | Amersham Health Salutar Inc. | Kontrastmittel |
US5650135A (en) | 1994-07-01 | 1997-07-22 | The Board Of Trustees Of The Leland Stanford Junior University | Non-invasive localization of a light-emitting conjugate in a mammal |
US5662885A (en) | 1994-07-22 | 1997-09-02 | Resolution Pharmaceuticals Inc. | Peptide derived radionuclide chelators |
GB9417941D0 (en) | 1994-09-06 | 1994-10-26 | Nycomed Imaging As | Improvements in or relating to contrast agents |
US5556939A (en) | 1994-10-13 | 1996-09-17 | Merck Frosst Canada, Inc. | TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications |
US6333021B1 (en) | 1994-11-22 | 2001-12-25 | Bracco Research S.A. | Microcapsules, method of making and their use |
DE4445065A1 (de) | 1994-12-07 | 1996-06-13 | Diagnostikforschung Inst | Verfahren zur In-vivo-Diagnostik mittels NIR-Strahlung |
IL116328A (en) | 1994-12-16 | 1999-09-22 | Bracco Research Sa | Frozen suspension of gas microbubbles in frozen aqueous carrier for use as contrast agent in ultrasonic imaging |
TW319763B (fr) | 1995-02-01 | 1997-11-11 | Epix Medical Inc | |
GB9502065D0 (en) | 1995-02-02 | 1995-03-22 | Nycomed Imaging As | Contrast media |
US5837680A (en) | 1996-02-16 | 1998-11-17 | Children's Medical Center Corporation | Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis |
EP0881915B1 (fr) | 1996-02-19 | 2003-04-23 | Amersham Health AS | Perfectionnements relatifs aux milieux de contraste |
AU726914B2 (en) | 1996-04-01 | 2000-11-23 | Epix Pharmaceuticals, Inc. | Bioactivated diagnostic imaging contrast agents |
JP3634869B2 (ja) | 1996-08-02 | 2005-03-30 | アメルシャム ヘルス アクスイェ セルスカプ | 造影剤における又はこれに関する改良 |
TR199901544T2 (xx) | 1996-10-21 | 1999-09-21 | Nycomed Imaging As | Kontrast ajanlar�ndaki veya kontrast ajanlar�yla ilgili geli�meler. |
ATE314097T1 (de) | 1996-10-28 | 2006-01-15 | Amersham Health As | Kontrastmittel |
EP0973552B1 (fr) | 1996-10-28 | 2006-03-01 | Amersham Health AS | Ameliorations apportees a des agents diagnostiques et/ou therapeutiques ou les concernant |
WO1998018497A2 (fr) | 1996-10-28 | 1998-05-07 | Nycomed Imaging As | Agents de contraste |
WO1998018495A2 (fr) | 1996-10-28 | 1998-05-07 | Marsden, John, Christopher | Ameliorations apportees a des agents diagnostiques et/ou therapeutiques ou les concernant |
EP0963209A2 (fr) | 1996-10-28 | 1999-12-15 | Marsden, John Christopher | Ameliorations apportees a des agents diagnostiques et/ou therapeutiques ou les concernant |
US5919967A (en) | 1997-04-11 | 1999-07-06 | Epix Medical, Inc. | Process for synthesizing phosphodiesters |
DE19717904A1 (de) | 1997-04-23 | 1998-10-29 | Diagnostikforschung Inst | Säurelabile und enzymatisch spaltbare Farbstoffkonstrukte zur Diagnostik mit Nahinfrarotlicht und zur Therapie |
US5886142A (en) | 1997-05-20 | 1999-03-23 | Thomas Jefferson University | Radiolabeled thrombus imaging agents |
US6245318B1 (en) | 1997-05-27 | 2001-06-12 | Mallinckrodt Inc. | Selectively binding ultrasound contrast agents |
IL120943A (en) | 1997-05-29 | 2004-03-28 | Univ Ben Gurion | A system for administering drugs through the skin |
GB9712525D0 (en) | 1997-06-16 | 1997-08-20 | Nycomed Imaging As | Method |
DE69819925T2 (de) | 1997-10-02 | 2004-09-02 | Epix Medical, Inc., Cambridge | Kontrastverstärktes Diagnosebildererzeugungsverfahren zur Überwachung von therapeutischen Eingriffen |
US6165458A (en) | 1997-12-26 | 2000-12-26 | Pharmaderm Laboratories Ltd. | Composition and method for dermal and transdermal administration of a cytokine |
CA2319433C (fr) | 1998-02-09 | 2008-04-22 | Bracco Research S.A. | Apport cible de milieux biologiquement actifs |
KR20010042288A (ko) * | 1998-03-31 | 2001-05-25 | 블레어 큐. 퍼거슨 | 신생혈관 형성 질환의 영상화용 약제 |
US6093382A (en) | 1998-05-16 | 2000-07-25 | Bracco Research Usa Inc. | Metal complexes derivatized with folate for use in diagnostic and therapeutic applications |
US6312665B1 (en) | 1998-12-21 | 2001-11-06 | Generex Pharmaceuticals Incorporated | Aerosol formulations for buccal and pulmonary application |
EP1151002A4 (fr) * | 1999-01-29 | 2002-05-02 | Imclone Systems Inc | Anticorps specifiques au kdr et leurs utilisations |
US6294525B1 (en) | 1999-09-01 | 2001-09-25 | Molecumetics Ltd. | Reverse-turn mimetics and methods relating thereto |
EP2286843A3 (fr) | 2000-06-02 | 2011-08-03 | Bracco Suisse SA | Composés pour le ciblage de cellules endothéliales |
WO2001097860A2 (fr) * | 2000-06-21 | 2001-12-27 | Bristol-Myers Squibb Pharma Company | Produits pharmaceutiques pour l'imagerie de troubles angiogeniques |
-
2003
- 2003-03-03 EP EP10185498.2A patent/EP2301587B1/fr not_active Expired - Lifetime
- 2003-03-03 EP EP03711418A patent/EP1572724A4/fr not_active Withdrawn
- 2003-03-03 CA CA002477836A patent/CA2477836A1/fr not_active Abandoned
- 2003-03-03 JP JP2003572527A patent/JP2006514915A/ja active Pending
- 2003-03-03 SI SI200332390T patent/SI2301587T1/sl unknown
- 2003-03-03 EP EP08008365A patent/EP2014310B8/fr not_active Expired - Lifetime
- 2003-03-03 ES ES08008365T patent/ES2398393T3/es not_active Expired - Lifetime
- 2003-03-03 WO PCT/US2003/006731 patent/WO2003074005A2/fr active Search and Examination
- 2003-03-03 ES ES10185498.2T patent/ES2506142T3/es not_active Expired - Lifetime
- 2003-03-03 AU AU2003213730A patent/AU2003213730A1/en not_active Abandoned
- 2003-03-03 CA CA2666005A patent/CA2666005C/fr not_active Expired - Lifetime
-
2009
- 2009-03-03 JP JP2009049512A patent/JP5039075B2/ja not_active Expired - Lifetime
- 2009-03-19 AU AU2009201114A patent/AU2009201114B2/en not_active Expired
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000063380A1 (fr) * | 1999-04-16 | 2000-10-26 | Genentech, Inc. | Variants du facteur de croissance endotheliale et utilisations correspondantes |
WO2001052875A1 (fr) * | 2000-01-18 | 2001-07-26 | Ludwig Institute For Cancer Research | Inhibiteur peptidomimetique de vegf-d/vegf-c/vegf |
WO2002016412A2 (fr) * | 2000-08-18 | 2002-02-28 | Dyax Corp. | Polypeptides de liaison pour proteine stimulatrice des lymphocytes b (blys) |
Non-Patent Citations (7)
Title |
---|
BINETRUY-TOURNAIRE ROSELYNE ET AL: "Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis", EMBO JOURNAL, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 19, no. 7, 3 April 2000 (2000-04-03), pages 1525 - 1533, XP002179245, ISSN: 0261-4189 * |
FAIRBROTHER W J ET AL: "NOVEL PEPTIDES SELECTED TO BIND VASCULAR ENDOTHELIAL GROWTH FACTOR TARGET THE RECEPTOR-BINDING SITE", BIOCHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, PA, US, vol. 37, no. 51, 22 December 1998 (1998-12-22), pages 17754 - 17764, XP000876734, ISSN: 0006-2960 * |
HAIYAN JIA ET AL: "PEPTIDES ENCODED BY EXON 6 OF VEGF INHIBIT ENDOTHELIAL CELL BIOLOGICAL RESPONSES AND ANGIOGENESIS INDUCED BY VEGF", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 283, no. 1, 2001, pages 164 - 173, XP002941058, ISSN: 0006-291X * |
IWAMOTO Y ET AL: "YIGSR, A SYNTHETIC LAMININ PENTAPEPTIDE, INHIBITS EXPERIMENTAL METASTATIS FORMATION", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, US, vol. 238, no. 4830, 20 November 1987 (1987-11-20), pages 1132 - 1134, XP001135169, ISSN: 0036-8075 * |
LECOUTER JENNIFER ET AL: "Identification of an angiogenic mitogen selective for endocrine gland endothelium", NATURE, NATURE PUBLISHING GROUP, LONDON, GB, vol. 412, no. 6850, 30 August 2001 (2001-08-30), pages 877 - 884, XP002194811, ISSN: 0028-0836 * |
SATO A K ET AL: "Development of mammalian serum albumin affinity purification media by peptide phage display", BIOTECHNOLOGY PROGRESS, XX, XX, vol. 18, no. 2, January 2002 (2002-01-01), pages 182 - 192, XP002348553, ISSN: 8756-7938 * |
SHRIVASTAVA A ET AL: "A distinct strategy to generate high-affinity peptide binders to receptor tyrosine kinases.", PROTEIN ENGINEERING, DESIGN & SELECTION : PEDS. SEP 2005, vol. 18, no. 9, September 2005 (2005-09-01), pages 417 - 424, XP002375785, ISSN: 1741-0126 * |
Also Published As
Publication number | Publication date |
---|---|
JP2006514915A (ja) | 2006-05-18 |
EP2014310B8 (fr) | 2012-12-26 |
ES2506142T3 (es) | 2014-10-13 |
JP5039075B2 (ja) | 2012-10-03 |
AU2009201114B2 (en) | 2012-01-19 |
EP2301587B1 (fr) | 2014-06-25 |
EP2014310A3 (fr) | 2009-09-09 |
EP1572724A2 (fr) | 2005-09-14 |
EP2014310B1 (fr) | 2012-10-24 |
CA2666005C (fr) | 2016-01-19 |
EP2014310A2 (fr) | 2009-01-14 |
AU2003213730A1 (en) | 2003-09-16 |
SI2301587T1 (sl) | 2014-11-28 |
EP2301587A2 (fr) | 2011-03-30 |
WO2003074005A2 (fr) | 2003-09-12 |
WO2003074005A8 (fr) | 2005-07-21 |
AU2009201114A1 (en) | 2009-04-09 |
EP2301587A3 (fr) | 2011-04-06 |
CA2477836A1 (fr) | 2003-09-12 |
CA2666005A1 (fr) | 2003-09-12 |
ES2398393T3 (es) | 2013-03-15 |
JP2009161549A (ja) | 2009-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003278807A8 (en) | KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy | |
EP1572724A4 (fr) | Peptides liant des recepteurs kdr et vegf/kdr et leurs utilisations en diagnostic et therapie | |
IL172316A0 (en) | Novel compounds and their use in therapy | |
IL174994A0 (en) | Pyrimidin - 4 - yl - 3, 4 - thione compounds and their use in therapy | |
IL172826A0 (en) | Quinoline derivates and their use in therapy | |
HK1081448A1 (en) | Bispecific anti-erb-b antibodies and their use in tumor therapy | |
IL173576A0 (en) | Use of polypeptides of the cupredoxin family in cancer therapy | |
ZA200703699B (en) | Nitrobenzindoles and their use in cancer therapy | |
EP1825005A4 (fr) | Agents diagnostiques et therapeutiques a base de mer | |
IL203007A0 (en) | Nogo-a binding with enhanced affinity and pharmaceutical use thereof | |
EP1781685A4 (fr) | Agents therapeutiques et diagnostiques | |
ZA200606225B (en) | Modified human four helical bundle polypeptides and their uses | |
SI1639013T1 (sl) | Pan-kir2dl nk-receptorska protitelesca in njihova uporaba pri diagnosticiranju in terapiji | |
AU2002364808A8 (en) | Polynucleotide and protein involved in synaptogenesis, variants thereof, and their therapeutic and diagnostic uses | |
HK1209050A1 (en) | Survivin-derived peptides and use thereof | |
PL1660532T3 (pl) | Polipeptydy fuzyjne i ich zastosowanie w przeciwnaczyniowej terapii guzów nowotworowych | |
AU2003209459A8 (en) | Protein-protein interactions in human tumours involving bcmp-7 and bcmp-11 | |
GB0402129D0 (en) | Therapeutic and diagnostic peptides | |
GB0321694D0 (en) | Genes and their therapeutic use | |
GB0424871D0 (en) | Antibodies and their use in therapy | |
GB0404199D0 (en) | Therapeutic and diagnostic peptides 2 | |
GB0225688D0 (en) | Therapeutic compounds and their use in therapy | |
IL173796A0 (en) | Polynucleotides, polypeptides and antibodies and use thereof in treating tsg101-associated diseases | |
GB0203043D0 (en) | Benzimidazloe compounds their preparation and their use in therapy | |
GB0203042D0 (en) | Anthraquinine compounds their preparation and their use in therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20041001 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
PUAK | Availability of information related to the publication of the international search report |
Free format text: ORIGINAL CODE: 0009015 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20060421 |
|
RA4 | Supplementary search report drawn up and despatched (corrected) |
Effective date: 20070214 |
|
17Q | First examination report despatched |
Effective date: 20071016 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20090505 |